...
首页> 外文期刊>Biochemistry and Cell Biology >Long non-coding RNA DSCAM-AS1 upregulates USP47 expression through sponging miR-101-3p to accelerate osteosarcoma progression
【24h】

Long non-coding RNA DSCAM-AS1 upregulates USP47 expression through sponging miR-101-3p to accelerate osteosarcoma progression

机译:长期非编码RNA DSCAM-AS1通过海绵MIR-101-3P来提高USP47表达,以加速骨肉瘤进展

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Osteosarcoma (OS) originating from mesenchyme is one of the most common invasive tumors of bone, and has an extremely high mortality rate. Previous studies have reported that long non-coding RNAs (lncRNAs) play essential roles in the tumorigenesis and progression of a multitude of human cancers. The lncRNA DSCAM-AS1 has been reported to be an oncogenic gene in many cancers. However, the roles and regulatory mechanisms of DSCAM-AS1 in OS have not been deeply investigated. In this study, our findings prove that DSCAM-AS1 is highly expressed in OS cells. Knockdown of DSCAM-AS1 suppressed cell proliferation, migration, and invasiveness, and induced cell apoptosis in OS. Additionally, knockdown of DSCAM-AS1 inactivated the Wnt-beta-catenin signaling pathway. Moreover, research into its molecular mechanisms confirmed that DSCAM-AS1 functions as a sponge for miR-101-3p, and that ubiquitin-specific peptidase 47 (USP47) is a target gene of miR-101-3p. Furthermore, a negative relationship between miR-101-3p and DSCAM-AS1 or USP47 was discovered. The results from our rescue assays suggest that DSCAM-AS1 regulates the progression of OS through binding with miR-101-3p to control the expression of USP47. Finally, we discovered that AKT-mTOR signaling pathway mediates the activity of DSCAM-AS1 in OS. Taken together, our results show that DSCAM-AS1 accelerates the progression of OS via the miR-101-3p-USP47 axis, which could present a new potential therapeutic treatment for OS.
机译:源自间充质的骨肉瘤(OS)是骨骼最常见的侵袭性肿瘤之一,具有极高的死亡率。以前的研究报道说,长期的非编码RNA(LNCRNA)在肿瘤发生和众多人类癌症的进展中起重要作用。据报道,LNCRNA DSCAM-AS1是许多癌症中的致癌基因。然而,OS中DSCAM-AS1的角色和监管机制尚未深入研究。在本研究中,我们的研究结果证明了DSCAM-AS1在OS细胞中高度表达。 DSCAM-AS1的敲低抑制细胞增殖,迁移和侵袭性,以及OS中的诱导细胞凋亡。另外,DSCAM-AS1的敲低灭活了WNT-β-Catenin信号传导途径。此外,进入其分子机制的研究证实,DSCAM-AS1用作miR-101-3p的海绵,泛素特异性肽酶47(USP47)是miR-101-3p的靶基因。此外,发现miR-101-3p和DSCAM-AS1或USP47之间的负相关关系。我们的救援测定结果表明,DSCAM-AS1通过与miR-101-3p结合来调节OS的进展,以控制USP47的表达。最后,我们发现AKT-MTOR信号通路在OS中介导DSCAM-AS1的活动。我们的结果表明,DSCAM-AS1通过MIR-101-3P-USP47轴加速了OS的进展,这可能为OS提供新的潜在治疗治疗。

著录项

  • 来源
    《Biochemistry and Cell Biology》 |2020年第5期|共12页
  • 作者单位

    Second Hosp Jilin Univ Dept Spine Surg Changchun 130000 Jilin Peoples R China;

    Second Hosp Jilin Univ Dept Rehabil Changchun 130000 Jilin Peoples R China;

    Second Hosp Jilin Univ Dept Traumat Orthoped Changchun 130000 Jilin Peoples R China;

    Jilin Univ Dept Orthoped China Japan Union Hosp Changchun 130031 Jilin Peoples R China;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 生物化学;
  • 关键词

    DSCAM-AS1; miR-101-3p; USP47; osteosarcoma;

    机译:DSCAM-AS1;MIR-101-3P;USP47;骨肉瘤;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号